Massachusetts Financial Services’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-577,417
Closed -$173M 929
2024
Q3
$173M Sell
577,417
-59,156
-9% -$17.8M 0.05% 304
2024
Q2
$210M Sell
636,573
-88,644
-12% -$29.2M 0.06% 256
2024
Q1
$287M Buy
725,217
+62,082
+9% +$24.6M 0.09% 210
2023
Q4
$234M Buy
663,135
+90,092
+16% +$31.7M 0.08% 226
2023
Q3
$215M Buy
+573,043
New +$215M 0.08% 229
2022
Q4
Sell
-322,183
Closed -$79.3M 892
2022
Q3
$79.3M Sell
322,183
-290,708
-47% -$71.5M 0.03% 371
2022
Q2
$185M Sell
612,891
-128,990
-17% -$39M 0.06% 257
2022
Q1
$305M Buy
741,881
+11,569
+2% +$4.75M 0.09% 200
2021
Q4
$343M Buy
730,312
+7,995
+1% +$3.75M 0.09% 191
2021
Q3
$307M Sell
722,317
-16,230
-2% -$6.89M 0.09% 199
2021
Q2
$265M Buy
738,547
+2,547
+0.3% +$915K 0.08% 217
2021
Q1
$207M Buy
736,000
+12,172
+2% +$3.43M 0.06% 253
2020
Q4
$205M Buy
723,828
+64,507
+10% +$18.3M 0.07% 245
2020
Q3
$181M Buy
659,321
+172,414
+35% +$47.4M 0.07% 230
2020
Q2
$111M Buy
486,907
+1,507
+0.3% +$342K 0.04% 298
2020
Q1
$73.9M Sell
485,400
-444,173
-48% -$67.6M 0.04% 316
2019
Q4
$140M Sell
929,573
-10,049
-1% -$1.51M 0.05% 262
2019
Q3
$133M Sell
939,622
-30,310
-3% -$4.3M 0.05% 262
2019
Q2
$121M Buy
969,932
+56,075
+6% +$7.02M 0.05% 274
2019
Q1
$101M Buy
913,857
+222,355
+32% +$24.5M 0.04% 287
2018
Q4
$67.8M Buy
691,502
+159,814
+30% +$15.7M 0.03% 338
2018
Q3
$65.6M Buy
531,688
+333,130
+168% +$41.1M 0.03% 363
2018
Q2
$19.7M Buy
198,558
+13,717
+7% +$1.36M 0.01% 516
2018
Q1
$16.3M Buy
184,841
+39,718
+27% +$3.51M 0.01% 530
2017
Q4
$14.3M Sell
145,123
-14,257
-9% -$1.41M 0.01% 564
2017
Q3
$15.3M Buy
+159,380
New +$15.3M 0.01% 536